Pentadecapeptide BPC (Oral)
Also known as: Oral BPC-157
Oral BPC-157 refers to stabilized oral preparations of the pentadecapeptide Body Protection Compound-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), most commonly the arginate salt (sometimes acetate or enteric-coated capsules), intended to survive gastric transit and improve absorption versus the unformulated peptide. This entry covers the salt/stabilized formulations specifically; generic BPC-157 capsules without a salt-form claim are classified under the base BPC-157 entry.
Who's worth your money for Pentadecapeptide BPC (Oral)
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
No sellers for Pentadecapeptide BPC (Oral) are indexed yet — we add vendors and their prices as we find them.
Watch Pentadecapeptide BPC (Oral)
Get one email when the market actually moves — no newsletter, no noise.
About Pentadecapeptide BPC (Oral)
CAS
137525-51-0
Molecular formula
C62H98N16O22
Sequence
GEPPPGKPADDAGLV
Typical dose range
250–500 mcg/day orally (1–2x daily), taken on an empty stomach; research use only
Half-life
<30 minutes (preclinical IV/IM data in rats and dogs; no published oral-specific human PK data)
No COAs on file for Pentadecapeptide BPC (Oral)
No independent third-party test has been located or submitted yet. Absence isn't a red flag — just no evidence catalogued for Pentadecapeptide BPC (Oral) so far; we add COAs as we find them.